background: It is generally acknowledged that the outcomes of IVF treatments are correlated between repeat cycles in the same couple and that these effects need to be allowed for in the analysis of such treatments. However, there are few studies that have attempted to estimate the magnitude of these effects or their clinical consequences.
Introduction
It is widely accepted that the outcomes of multiple infertility treatments for the same couple are not independent (Dias et al., 2008) and this has consequences for the analysis of outcome data from such treatments. These correlations between repeat cycles of treatment in the same couples reflect the fact that the factors affecting prognosis for any individual are not fully known and there are (unmeasured) patient characteristics which affect positively or negatively the outcomes of all treatment cycles for any given couple. The nonindependence of cycle outcomes from the same couples can be considered equivalently as a correlation between treatment outcomes or as heterogeneity between patients with similar characteristics. The need to allow for such non-independence in study design and analysis is widely acknowledged, particularly in the context of clinical trials (Vail and Gardener, 2003; Makubate and Senn, 2010) .
In clinical practice, treatment failure in a previous cycle is seen as a potential indicator of poorer prognosis for future treatments, independently of other factors. In cross-sectional data, a reduction in treatment success rates is seen with increasing attempt number (e.g. Templeton et al., 1996; Hirst et al., 2011; Nelson and Lawlor, 2011) , although these effects are at least in part attributable to patient selection with a complex set of policy, financial, clinical and psychological factors determining which patients receive multiple treatments.
The hypothetical modelling study of Dias et al. (2008) investigated the role of correlations between repeat treatments in determining the success rates of subsequent treatments following one or more failures. Taking a single attempt at achieving pregnancy, this work assumed that individual couples have differing underlying potential success rates and therefore those failing in the first cycles and receiving subsequent cycles would be more likely to be those of poorer prognosis. Thus, the existence of inter-patient heterogeneity in prognosis directly leads to a decrease in success rates across cycles in observed data.
In the analysis of observational data, there have been a few attempts to allow for intra-patient correlations, mainly treating these as nuisance variables (e.g. Templeton et al., 1996; Hirst et al., 2011; Jonsdottir et al., 2011) , but more often they are ignored (e.g. Baker et al., 2010) or only one cycle per patient is selected or an argument is made that the effects are small (e.g. Roberts et al., 2010a; Nelson and Lawlor, 2011) . It has been argued that the omission of these correlations makes little difference to the model estimates and predictions (Templeton et al., 1996; Roberts et al., 2010a; Nelson and Lawlor, 2011) except where one explicitly needs to predict across multiple cycles from the same individual (e.g. Roberts et al., 2010b; Roberts et al., 2011) . For such modelling studies, estimates of the correlations between cycles are needed. Additionally, the magnitude of the effects may illuminate the degree to which there are still unidentified prognostic factors to be identified.
There is very little previous work which attempts to explicitly quantify the magnitude of the correlations between repeat cycles: we are only aware of our own work (Roberts et al., 2010a; Hirst et al., 2011) . This is largely due to the fact that these analyses are technically and computationally challenging.
The EU model, although underutilized, provides a rich framework within which to represent the embryo-implantation process. The model explicitly includes prognostic factors that act on the individual embryos and those which act on the recipient patient, with logistic regression sub-models for the two components. Although initially derived based on a specific biological mechanism involving embryo viability and uterine receptivity (Speirs et al., 1983; Zhou and Weinberg, 1998) it has a structure which readily accommodates a wider range of treatment and clinical factors. As such it can be conceived as a multilevel model with factors acting at either the patient or the embryo level whilst allowing for the lack of knowledge of individual embryo fates within multiple embryo transfers. The EU model structure explicitly allows, through the common U component, for correlations between embryos within each cycle, but until recently it has not been possible to include correlations between embryos from the same patients across multiple cycles.
This present work utilizes extensions to the EU model which include correlations between repeat cycles in the same patients by adding inter-patient heterogeneity (in a random intercept form) in either the embryo or the patient sub-model. We utilize a large multicentre UK data set which has sufficient detail and size to allow reliable estimation of the effects (Roberts et al., 2010a) . We estimate the magnitude of these effects and their influence on model parameter estimates along with consideration of the implications for prediction of outcomes following one or more treatment failures.
Materials and Methods
The data set has been described previously (Roberts et al., 2010a) and the main characteristics of the data set analysed here are summarized briefly in Table I . It consists of routinely collected data from five UK treatment centres covering the range of UK practice and including NHS, fee-paying and private centres. A total of 12 480 fresh cycles from 8768 couples treated between 2000 and 2005 are included in the analyses presented here. The variables include patient and treatment characteristics and embryo grades of all transferred embryos. Most transfers were of double embryos (83%) with 11% single and 6% triple.
The data are fitted using an EU model framework, which comprises two logistic regression sub-models describing the embryo and uterine components of the success. The model requires that for an embryo to develop it must both be viable (positive outcome from the embryo component) and have a receptive uterus (positive outcome from the uterine component). Details of the model and fitting process as used here have been described previously (Roberts, 2007) . For the work here, we add a patient-level random effect term to either the embryo or uterus sub-model which can be thought of as representing unmeasured covariates specific to each patient-an individual measure of prognosis. Formally the probability E ijk of embryo k in cycle j for patient i being viable and the corresponding probability of the uterus being receptive, U ij , is given by:
where X Eijk and X Uij are covariate matrices for the E and U sub-models and b E and b U the corresponding parameter vectors. The u Ei and u Ui are the added random effects which are assumed to be normally distributed with zero mean and variances s The non-independence of IVF treatment outcomes the probability of a live birth in cycle j for patient i is given simply by U ij E ij1 . For double embryo transfer, the probability of a singleton birth is given by
The models are fitted by direct maximization of the observed data likelihood using custom-written software implemented using the ml procedure in Stata. Intergration over the random effects utilized Gauss-Hemite quadrature with a minimum of 16 integration points and the results confirmed by increasing the number of points (Stylianou, 2011) . We present models without any random effects and with a random effect added to either the U or the E sub-model. Whilst it is possible in principal to fit a model which includes random effects in both sub-models, this is (unsurprisingly) not identified in this data set. Predicted outcomes are presented as both population averages over the patient variability (s 2 E or s 2 U ) and as empirical Bayes estimates which give predictions for future cycles given the outcomes (in this case negative) of previous cycles.
All the analyses here used live birth (number of babies) as the outcome measure and the covariates included were based on previous work with this data set (Roberts et al., 2010a) . In order to simplify the presentation, the full model presented in the earlier work has been somewhat simplified by removing non-significant covariates and using a categorical representation of embryo cell growth and grade rather than a spline representation. The simplified model gives virtually identical results to the full model described earlier. Cell growth is represented as doublings per day [i.e. log 2 (cell number)/(days in culture)] and classified as slow (,0.7), normal (0.7-1.0) or fast (≥1.0). Grade was based on Steer et al. (1992) . The assignment of prognostic factors to either the E or U submodel follows that described previously and utilized a combination of clinical knowledge and statistical selection. The model selection procedure of the previous work led to the inclusion of treatment attempt number in the U sub-model. As the effect of attempt number is critical to the understanding of the effects of inter-cycle correlations, we also considered variants of the model in which attempt was fitted in the E, the U or both model components.
The model parameters are shown as odds ratios with 95% CI. The between-patient variances s 2 E and s 2 U are shown as median odds ratios (MOR) (Larsen and Merlo, 2005) : these estimate the median odds ratio of response between the higher and lower of any two randomly selected patients. Models are compared using the Akiake Information criterion (AIC) which provides a measure of the goodness of fit allowing for the number of parameters fitted. Model fit is quantified using the standard area under the receiver -operator characteristics curve (AUC), with three non-independent values for no birth, singleton and multiple births. Hypothesis tests are based on likelihood ratio tests between appropriately chosen models. Table II shows the fitted model parameters for the three variants: no correlation between cycles, correlation in the U sub-model and correlation in the E sub-model. The estimates from the model with U sub-model correlations are almost identical to that when the correlation is omitted, with only a very marginal increase in the uncertainty (as shown by the width of the 95% CI). This has been noted before (Templeton et al., 1996; Roberts et al., 2010a; Hirst et al., 2011; Nelson and Lawlor, 2011 ) based on less sophisticated approaches. There are rather larger differences in the estimates when we allow for correlations in the E sub-model, although these are still rather small on any practical scale.
Results
The correlations themselves are however not small, with estimates in terms of the inter-patient heterogeneity giving median odds ratios of around 2. That is, after taking into account all the measured prognostic factors (age, history, embryo grade, etc.), any two randomly chosen otherwise identical couples have a factor of 2 difference in their odds of conceiving.
Formal comparison of the fits (Table III) indicates that the model with embryo sub-model correlations is the best fit to the data and a statistically significant improvement on the uncorrelated model. However, in terms of prediction, the three models have virtually identical AUC measures, these reflecting the very similar model predictions in a single cycle. In Fig. 1 , we show the predicted live birth (singleton or multiple) and multiple birth probabilities for the two correlated models compared with the standard uncorrelated model. We see that the correlated models give almost identical predictions for individual outcomes, but that adding correlation to the E sub-model does show greater differences in individual predictions and a slight tendency to predict higher twin rates. As shown in Table II the effect of treatment attempt is somewhat diminished if we allow for embryolevel correlations. This effect is examined more closely in Table IV where we note that the effect of attempt which was highly significant if we ignore correlations loses statistical significance in the presence of inter-cycle correlations. These conclusions are not sensitive to the choice of sub-model chosen for the attempt number covariate (data not shown). However, we note from Table II that the effect estimates themselves are not greatly diminished. Within the correlated EU model, it is possible to obtain estimates of the outcomes in couples given that they have had one or more previous failures (this is analogous to the estimates produced by Dias et al. (2008) ). These so-called empirical Bayes estimates are shown, for a typical couple in Fig. 2 , alongside the estimates from the uncorrelated model. Here we see that (upper panels) if we ignore correlations we would see only a modest loss in success as the number of treatment failures increases, and this loss is smaller in single embryo transfer (SET) compared with double embryo transfer (DET) cycles. In contrast if we allow for correlations, previous failures do suggest a more substantial drop in live birth rate. When considering live birth outcomes, the two correlated models yield similar predictions. Interestingly, this is not so for twin rates (Fig. 2, lower panels) where the presence of E-level correlations leads to a prediction that for any individual couple having a number of previous failures implies their expected twin rate will be modestly lowered in subsequent cycles. When there is appreciable inter-patient variability in embryo viability, couples with failures will have, on average, poorer quality embryos and the probability of twins given pregnancy is dependent on the viability of the second embryo. In contrast U sub-model correlations imply that the couples with failures have an overall reduced probability of success due to non-embryo factors, and therefore if there is a live birth then the proportion that produces twins is not changed.
Discussion
Previous work has only considered inter-cycle correlations in IVF outcomes in a limited way, here we have exploited the EU model approach to look at such correlations between both embryo viability and the couples receptivity between repeat cycles from the same couple. The data here suggest strongly that there are such correlations and that they act predominantly through the embryo component. 
Continued
The non-independence of IVF treatment outcomes patient which substantially affect embryo viability and which are not measured with the covariates considered here. Such factors may include a propensity towards chromosomal aneuploidy or other genetic factors beyond those simply associated with increasing chronological age or identified as differences in morphological grade.
The estimates of the magnitude of the inter-cycle correlation are surprisingly large, with median odds ratios of around 2 between any two randomly selected, otherwise identical, couples. This suggests that there is still considerable scope for determining factors which predict outcome, particularly those affecting embryo viability. These may include improved grading (Cutting et al., 2008 ; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011) or novel biomarkers (e.g. Brison et al., 2004; Seli et al., 2007; Katz-Jaffe et al., 2009 ). Culture to blastocyst stage resolves some of the embryo uncertainty during cell culture and it might be informative to compare these estimates with those from repeat blastocyst transfers. Similar magnitude effects have been seen in a cruder analysis of the same data set (Roberts et al., 2010a) , in a simpler analysis of the UK national data (Hirst et al., 2011) and in an analysis of the latter data using an EU approach (Roberts, unpublished) . These estimates compare with a larger MOR of 3.3 (95% CI: 2.9-4.0) if no covariates are included in the model.
The presence of such correlations does suggest that previous treatment failure is indeed prognostic. Estimates of the effect of such failures from cross-sectional data show a decreased live birth rate with increasing attempt number, but these estimates are inevitably biased as patient choice and treatment policy means that the patient groups having different numbers of cycles are composed of patients with different characteristics and prognosis. Estimates such as those of Fig. 2 give direct estimates of the losses expected for individual patients following treatment failure. Although greater than would be estimated from cross-sectional data, these losses are actually quite modest and suggest that in excess of 10 treatment failures are required to reduce the chances of subsequent success by half (and even more in SET cycles). This has implications for the counselling of couples as it implies that a treatment failure should be considered more a matter of bad luck and only slightly lowers their chances for subsequent treatments. It also has implications for policy-makers as it suggests that rationing patients to only a small number of treatments has little clinical justification. We confirm previous results using an EU approach (Roberts et al., 2010a) that correlations between patient receptivities have negligible effect on the parameter estimates or predictive accuracy of the models. In contrast correlations between embryo viabilities do have an, albeit small, effect on the parameter estimates, and do have a small effect on the model predictions. Given the inherent biases and uncertainties in observational data sets, this is likely to be a minor problem for the practical application of such models.
Although the data set here is large, the proportion of repeat cycles is relatively small. The limitations of the data set have been discussed previously (Roberts et al., 2010b) , and it is possible that the intra-patient effects seen here as correlations might be associated with unmeasured or poorly measured covariates. The data here relate to fresh, cleavage stage, transfers and it would be informative to investigate the correlations between fresh and frozen embryos and whether blastocyst transfer provides further information which reduces the effects.
In conclusion we have shown that it is possible to identify and estimate substantial correlations between embryo-transfer cycles from the same couples. These correlations have been shown to be predominately associated with inter-patient differences in embryo viability rather than with patient factors, although some influence of both cannot be ruled out. Whilst the bias induced in predictive models is small, the magnitude of the effects suggests that there are still important factors relating to embryo viability to be identified. These effects do need to be incorporated in any modelling or prediction concerning multi-cycle outcomes. The magnitude of the correlations suggests that for any individual couple previous cycle failures do not imply a greatly reduced prognosis for future cycles.
